- Home
- KROS vs EIM Comparison
KROS vs EIM Comparison
Compare KROS & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | EIM |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 499.9M |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KROS | EIM |
|---|---|---|
| Price | $11.49 | $9.82 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.86 | N/A |
| AVG Volume (30 Days) | ★ 335.5K | 142.0K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $243,864,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,751.79 | N/A |
| P/E Ratio | $5.02 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.42 | $9.41 |
| 52 Week High | $22.55 | $10.54 |
Technical Indicators
Market Signals| Indicator | KROS | EIM |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 50.64 |
| Support Level | $10.56 | $9.66 |
| Resistance Level | $12.65 | $10.02 |
| Average True Range (ATR) | 0.42 | 0.09 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 37.50 | 75.56 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About EIM Eaton Vance Municipal Bond
Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.